Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Am J Med Genet B Neuropsychiatr Genet. 2014 Jul 25;0(6):457–466. doi: 10.1002/ajmg.b.32257

TABLE III.

Differentially-Expressed Genes that Participate in Identified KEGG Pathways

Gene ID Gene Product Additional KEGG Pathways
Phosphatidylinositol Signaling System (PSS)
 Calm2 Calmodulin 2 LTP. ISP. AD
 Calm3 Calmodulin 3 LTP
 Dgkg Diacylglycerol kinase γ
Cardiac Muscle Contraction (CMC)
 1110020P15 Rik RIKEN cDNA PD, AD, HD
 Atp1b1 ATPase, Na+/K+, β1 subunit
 Atp1b2 ATPase, Na+/K+, β2 subunit
 Cox5b Cytochrome c oxidase, subunit Vb PD, AD, HD
 Cox6a1 Cytochrome c oxidase, subunit VIa, polypeptide1 PD, AD, HD
 Cox 6b1 Cytochrome c oxidase, subunit VIb, polypeptide 1 PD, AD, HD
 Cox7a2l Cytochrome c oxidase, subunit VIIa, polypeptide 2-like PD, AD, HD
 Uqcr Ubiquinol-cytochrome c reductase subunit PD, AD, HD
 Uqcrc2 Ubiquinol-cytochrome c reductase core protein 2 PD, AD, HD
 Uqcrh Ubiquinol-cytochrome c reductase hinge protein PD, AD, HD
Gap Junction (GJ)
 Gja1 Gap junction protein, α1
 Tuba1a Tubulin, α 1A
 Tuba1b Tubulin, α 1B
 Tubb4 Tubulin, β 4
 Tubb5 Tubulin, β 5
Long-Term Potentiation (LTP)
 Calm2 Calmodulin 2 PSS
 Calm3 Calmodulin 3 PSS, ISP, AD
 Ppp1ca Protein phosphatase 1, catalytic subunit, α isoform ISP
Insulin Signaling Pathway (ISP)
 Calm2 Calmodulin 2 PSS, LTP, AD
 Calm3 Calmodulin 3 PSS, LTP, AD
 Ppp1ca Protein phosphatase 1, catalytic subunit, α isoform LTP
 Prkar1a Protein kinase, cAMP dependent, type I, α
 Rps6 Ribosomal protein S6 R
Parkinson’s Disease (PD)
 1110020P15 Rik RIKEN cDNA CMC, AD, HD
 Atp5b ATP synthase, H+ transporting, MT F1 complex, β subunit AD
 Atp5g3 ATP synthase, H+ transporting, MT F0 complex, subunit c, iso 3 AD, HD
 Cox7a2l Cytochrome c oxidase, subunit VIIa, polypeptide 2-like CMC, AD, HD
 Ndufa10 NADH dehydrogenase (ubiquinone), 1α, subcomplex 10 AD, HD
 Ndufa2 NADH dehydrogenase (ubiquinone), 1α, subcomplex 2 AD, HD
 Ndufa3 NADH dehydrogenase (ubiquinone), 1α, subcomplex 3 AD, HD
 Ndufa7 NADH dehydrogenase (ubiquinone), 1α, subcomplex 7 AD, HD
 Ndufv1 NADH dehydrogenase (ubiquinone) flavoprotein 1 AD, HD
 Snca Synuclein, α AD
 Ubb Ubiquitin B
 Uchl1 Ubiquitin carboxyterminal hydrolase L1
 Uqcr Ubiquinol-cytochrome c reductase subunit CMC, AD, HD
 Uqcrc2 Ubiquinol-cytochrome c reductase core protein 2 CMC, AD, HD
 Uqcrh Ubiquinol-cytochrome c reductase hinge protein CMC, AD, HD
Ribosomes (R)
 Rpl10 Ribosomal protein 10
 Rpl10a Ribosomal protein L10a
 Rpl24 Ribosomal protein 24
 Rpl27 Ribosomal protein 27
 Rpl41 Ribosomal protein L41
 Rpl9 Ribosomal protein L9
 Rplp1 Ribosomal protein, large, P1
 Rps12 Ribosomal protein S12
 Rps14 Ribosomal protein S14
 Rps16 Ribosomal protein S16
 Rps2 Ribosomal protein S2
 Rps6 Ribosomal protein S6 ISP
 Rps21 Ribosomal protein S21
 Rps29 Ribosomal protein S29
 Rps4x Ribosomal protein S4, X-linked
 Rps7 Ribosomal protein S7
 Rps9 Ribosomal protein S9
Alzheimer’s Disease (AD)
 Apbb1 Amyloid β precursor protein-binding, family B, 1
 Atp5b ATP synthase, H+ transporting, MT F1 complex, β subunit PD
 Atp5g3 ATP synthase, H+ transporting, MT F0 complex, subunit c, isoform 3 PD, HD
 Calm2 Calmodulin 2 PSS, LTP, ISP
 Calm3 Calmodulin 3 PSS, LTP, ISP
 Cox5b Cytochrome c oxidase, subunit Vb CMC, PD, HD
 Cox6a1 Cytochrome c oxidase, subunit VIa, polypeptide1 CMC, PD, HD
 Cox 6b1 Cytochrome c oxidase, subunit VIb, polypeptide 1 CMC, PD, HD
 Cox7a2l Cytochrome c oxidase, subunit VIIa, polypeptide 2-like CMC, PD, HD
 Ndufa10 NADH dehydrogenase (ubiquinone), 1α, subcomplex 10 PD, HD
 Ndufa2 NADH dehydrogenase (ubiquinone), 1α, subcomplex 2 PD, HD
 Ndufa3 NADH dehydrogenase (ubiquinone), 1α, subcomplex 3 PD, HD
 Ndufa7 NADH dehydrogenase (ubiquinone), 1α, subcomplex 7 PD, HD
 Ndufv1 NADH dehydrogenase (ubiquinone) flavoprotein 1 PD, HD
 Snca Synuclein, α PD
 Uqcr Ubiquinol-cytochrome c reductase subunit CMC, PD, HD
 Uqcrc2 Ubiquinol-cytochrome c reductase core protein 2 CMC, PD, HD
 Uqcrh Ubiquinol-cytochrome c reductase hinge protein CMC, PD, HD
Huntington’s Disease (HD)
 1110020P15Rik RIKEN cDNA CMC, PD, AD
 Atp5g3 ATP synthase, H+ transporting, MT F0 complex, subunit c, iso 3 PD, AD
 Cox5b Cytochrome c oxidase, subunit Vb CMC, PD, AD
 Cox6a1 Cytochrome c oxidase, subunit VIa, polypeptide1 CMC, PD, AD
 Cox 6b1 Cytochrome c oxidase, subunit VIb, polypeptide 1 CMC, PD, AD
 Cox7a2l Cytochrome c oxidase, subunit VIIa, polypeptide 2-like CMC, PD, AD
 Gpx1 Glutathioneperoxidase 1
 Ndufa10 NADH dehydrogenase (ubiquinone), 1α, subcomplex 10 PD, AD
 Ndufa2 NADH dehydrogenase (ubiquinone), 1α, subcomplex 2 PD, AD
 Ndufa3 NADH dehydrogenase (ubiquinone), 1α, subcomplex 3 PD, AD
 Ndufa7 NADH dehydrogenase (ubiquinone), 1α, subcomplex 7 PD, AD
 Ndufv1 NADH dehydrogenase (ubiquinone) flavoprotein 1 PD, AD
 Uqcr Ubiquinol-cytochrome c reductase subunit CMC, PD, AD
 Uqcrc2 Ubiquinol-cytochrome c reductase core protein 2 CMC, PD, AD
 Uqcrh Ubiquinol-cytochrome c reductase hinge protein CMC, PD, AD

Pathways are presented in decreasing order of impact factors, as in Table II. Phosphatidylinositol signaling system, PSS; Cardiac muscle contraction, CMC; Gap junction, GJ; Long-term potentiation, LTP; Insulin signaling pathway, ISP; Parkinson’s disease, PD; Alzheimer’s disease, AD; Huntington’s disease, HD.